Snezana T. Dimova

Snezana T. Dimova

Auto-generated profile, based on publicly available information

Snezana T. Dimova

Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2026 in RSC Advances
Verified
Journal Article
Open access
FWFeijun Wang
Feijun Wang
JHJohn N. Hanson
John N. Hanson
SDSnezana T. Dimova
Snezana T. Dimova
JRJayachandra Rayadurgam
Jayachandra Rayadurgam
CFCamryn J. Fulton
Camryn J. Fulton
KFKevin J. Frankowski
Kevin J. Frankowski
The D 1 dopamine receptor (D 1 R) ligand BMS Compound A is a positive allosteric modulator (PAM) of D 1 R signaling.

23 October 2026 in Science Advances
Verified
Journal Article
Closed access
KWKai Wang
Kai Wang
SDSnezana T. Dimova
Snezana T. Dimova
JHJohn N. Hanson
John N. Hanson
ATAbhishek Thakur
Abhishek Thakur
YXYouwei Xu
Youwei Xu
YZYouwen Zhuang
Youwen Zhuang
Allosteric modulation of G protein–coupled receptors (GPCRs) offers promising therapeutic opportunities. Although multiple allosteric binding sites have been identified in GPCRs, whether and how these spatially distinct sites cooperate to regulate receptor activation remain poorly understood. Here, we elucidate the molecular mechanism of cooperative multisite allostery in the dopamine D1 receptor (D1R). We developed two novel D1R positive allosteric modulators (PAMs), UNC9815 and UNC10062, and used cryo–electron microscopy to structurally identify two previously uncharacterized D1R allosteric sites occupied by UNC9815/UNC10062 and another D1R PAM, BMS-A1. Both sites localize to the transmembrane helix (TM) 1 to 7 interface as vertically adjacent allosteric pockets organized in a spatially complementary manner. Our structures demonstrate the simultaneous binding of the chemically distinct PAMs (LY3154207, BMS-A1, and UNC9815/UNC10062) in three nonoverlapping pockets. Concurrent engagement of all three allosteric sites produces pronounced functional cooperativity, increasing dopamine potency by >1000-fold, thereby demonstrating that coordinated multisite modulation can achieve substantial pharmacological amplification beyond the limits imposed by single PAM administration. Molecular dynamics (MD) simulations revealed that multisite PAM engagement restricts intracellular loop 3 dynamics and stabilizes the TM7-NPxxY activation motif, effects not achieved by binding of LY3154207 alone, thereby biasing the receptor toward a more stabilized active conformation, and may also improve agonist potency by stabilizing extracellular loop 2. Together, these findings establish the structural framework for cooperative multisite allostery in a GPCR, revealing how distributed allosteric sites act in concert to amplify receptor activation and providing a conceptual foundation for developing innovative GPCR allosteric therapeutics.